Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_assertion type Assertion NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_head.
- NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_assertion description "[We conducted a GWAS among 1116 subjects with Major Depressive Disorder from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial who were characterized using Growth Mixture Modeling as showing a sustained versus unsustained pattern of clinical response over 12 weeks of treatment with citalopram.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_provenance.
- NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_assertion evidence source_evidence_literature NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_provenance.
- NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_assertion SIO_000772 23726668 NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_provenance.
- NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_assertion wasDerivedFrom befree-20140225 NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_provenance.
- NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_assertion wasGeneratedBy ECO_0000203 NP530016.RAT6vdWCNGNlRMM0U-Wz3HsE33VAwbFEzzckehIusktIU130_provenance.